RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.
复制标题
DOI:
10.1007/s12032-023-01960-8
复制
发表时间:
2023-03-10
期刊:
影响因子:
3.4
通讯作者:
Li, Juan
中科院分区:
文献类型:
--
作者:
Huang, Beihui;Liu, Huixin;Chan, Szehoi;Liu, Junru;Gu, Jingli;Chen, Meilan;Kuang, Lifen;Li, Xiaozhe;Zhang, Xingding;Li, Juan
RUNX2 is a transcription factor that participates in osteoblast differentiation and chondrocyte maturation and plays an important role in the invasion and metastasis of cancers. With the deepening of research, evidence has indicated the correlation between RUNX2 and bone destruction in cancers. However, the mechanisms underlying its role in multiple myeloma remain unclear. By observing the induction effects of conditioned medium from myeloma cells on preosteoblasts (MC3T3-E1) and preosteoclasts (RAW264.7) and constructing myeloma-bearing mice, we found that RUNX2 promotes bone destruction in multiple myeloma. In vitro, conditioned medium from RUNX2-overexpressing myeloma cells reduced osteoblast activity and increased osteoclast activity. In vivo, RUNX2 expression was positively correlated with bone loss in myeloma-bearing mice. These results suggest that therapeutic inhibition of RUNX2 may protect against bone destruction by maintaining the balance between osteoblast and osteoclast activity in multiple myeloma.
登录
查看更多内容
影响因子:
3.8
作者:
McDonald MM;Kim AS;Mulholland BS;Rauner M
通讯作者:
Rauner M
影响因子:
3.8
作者:
Sadikovic, Bekim;Thorner, Paul;Zielenska, Maria
通讯作者:
Zielenska, Maria
DOI:
10.1158/1541-7786.mcr-17-0606
发表时间:
2018-07
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Gowda PS;Wildman BJ;Trotter TN;Xu X;Hao X;Hassan MQ;Yang Y
通讯作者:
Yang Y
DOI:
10.4068/cmj.2016.52.1.12
发表时间:
2016-01
期刊:
Chonnam medical journal
影响因子:
--
作者:
Kim JH;Kim N
通讯作者:
Kim N
影响因子:
6
作者:
Kim JM;Lin C;Stavre Z;Greenblatt MB;Shim JH
通讯作者:
Shim JH